Qigong for pre & stage 1 hypertension : A randomized controlled trial

Korea Institute of Oriental Medicine0 个研究点目标入组 52 人开始时间: 待定最近更新: 2019年3月11日

适应症

试验速览

暂无简介。

•1. Men and women, aged 19 to 65 years
•2. Blood pressure is in the prehypertension stage or at stage 1 hypertension (systolic blood pressure of 120-159 mmHg or diastolic blood pressure of 80-99 mmHg) (by the Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure criteria)
•3. Provide consent to participate in this trial and sign an informed consent statement

•1. Taking medicine for blood pressure control, such as prescription or over the counter drug or herb/supplements
•2. Secondary hypertension
•3. Previous cerebrovascular or heart disease such as myocardial infarction, angina and valvular disease
•4. Wasting disease
•5. Insulin or diabetes medication in diabetic patients
•6. Previous kidney, liver or hyperthyroidism
•7. Active tuberculosis and other infectious disease
•8. Systemic steroids or immunosuppressive therapy
•9. Oral contraceptives, central nervous system inhibitors or stimulants, such as taking medication that affects blood pressure
•10. Pregnant women, lactating and pregnant women who plan on
•11. Others whose clinical trials conductors are considered inappropriate for participating in this trial

发起方